231 related articles for article (PubMed ID: 28476519)
1. The underutilisation of dual antiplatelet therapy in acute coronary syndrome.
Anastasius M; Lau JK; Hyun K; D'Souza M; Patel A; Rankin J; Walters D; Juergens C; Aliprandi-Costa B; Yan AT; Goodman SG; Chew D; Brieger D
Int J Cardiol; 2017 Aug; 240():30-36. PubMed ID: 28476519
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
[TBL] [Abstract][Full Text] [Related]
3. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
[TBL] [Abstract][Full Text] [Related]
4. Trends of prescribing adherence of antiplatelet agents in Hong Kong patients with acute coronary syndrome: a 10-year retrospective observational cohort study.
Lam AS; Yan BP; Lee VW
BMJ Open; 2020 Dec; 10(12):e042229. PubMed ID: 33273050
[TBL] [Abstract][Full Text] [Related]
5. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry).
Cheng CI; Chen CP; Kuan PL; Lei MH; Liau CS; Ueng KC; Wu CJ; Lai WT
Clin Cardiol; 2010 Jun; 33(6):E40-8. PubMed ID: 20552592
[TBL] [Abstract][Full Text] [Related]
6. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study.
Bardají A; Leal M; Arrarte V; Garcia-Moll X; Pérez de Isla L; Bueno H
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27885830
[TBL] [Abstract][Full Text] [Related]
7. Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registry.
Schiele F; Puymirat E; Bonello L; Dentan G; Meneveau N; Collet JP; Motreff P; Ravan R; Leclercq F; Ennezat PV; Ferrières J; Berard L; Simon T; Danchin N
Int J Cardiol; 2015; 187():354-60. PubMed ID: 25839641
[TBL] [Abstract][Full Text] [Related]
8. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study.
Sawhney JPS; Mullasari A; Kahali D; Mehta V; Nair T; Kaul U; Hirematth MS
Indian Heart J; 2019; 71(1):25-31. PubMed ID: 31000179
[TBL] [Abstract][Full Text] [Related]
10. Impact of Chronic Antiplatelet Therapy on Infarct Size and Bleeding in Patients With Acute Myocardial Infarction.
Campodonico J; Cosentino N; Milazzo V; Rubino M; De Metrio M; Marana I; Moltrasio M; Grazi M; Lauri G; Bonomi A; Veglia F; Chiorino E; Assanelli E; Bartorelli AL; Marenzi G
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):407-413. PubMed ID: 29669424
[TBL] [Abstract][Full Text] [Related]
11. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting.
Choi KH; Song YB; Jeong DS; Jang YH; Hong D; Lee SY; Youn T; Bak M; Min KM; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Chung SR; Cho YH; Sung K; Kim WS; Gwon HC; Lee YT
Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):517-526. PubMed ID: 33075126
[TBL] [Abstract][Full Text] [Related]
13. Impact of extended dual antiplatelet therapy on clinical prognosis in acute coronary syndrome patients with intermediate or high ischemic risk defined by the GRACE score.
Bian L; Qiu M; Li Y; Xu X; Li J; Ma S; Qi Z; Han Y
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():665-673. PubMed ID: 31957965
[TBL] [Abstract][Full Text] [Related]
14. Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study.
Angerås O; Hasvold P; Thuresson M; Deleskog A; ÖBraun O
Scand Cardiovasc J; 2016; 50(2):99-107. PubMed ID: 26564402
[TBL] [Abstract][Full Text] [Related]
15. Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia.
Zou Y; Yang S; Wang S; Lv B; Xiu L; Li L; Lee SW; Chin CT; Pocock SJ; Huo Y; Yu B
Clin Cardiol; 2020 Apr; 43(4):346-354. PubMed ID: 31967663
[TBL] [Abstract][Full Text] [Related]
16. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome.
Varenhorst C; Jensevik K; Jernberg T; Sundström A; Hasvold P; Held C; Lagerqvist B; James S
Eur Heart J; 2014 Apr; 35(15):969-78. PubMed ID: 24122961
[TBL] [Abstract][Full Text] [Related]
17. Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
Ribera A; Ferreira-Gonzalez I; Marsal JR; Oristrell G; Faixedas MT; Rosas A; Tizón-Marcos H; Rojas S; Labata C; Cardenas M; Homs S; Tomas-Querol C; Garcia-Picart J; Gomez-Hospital JA; Pijoan JI; Masotti M; Mauri J; Garcia Dorado D;
BMJ Open; 2019 Jul; 9(7):e028114. PubMed ID: 31340964
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome: A nationwide long-term registry analysis from 2009 to 2014.
Sheikh Rezaei S; Geroldinger A; Heinze G; Reichardt B; Wolzt M
Int J Cardiol; 2017 May; 235():61-66. PubMed ID: 28262344
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
Cerrato E; Giacobbe F; Quadri G; Macaya F; Bianco M; Mori R; Biolè CA; Boi A; Bettari L; Rolfo C; Ferrari F; Annibali G; Scappaticci M; Pavani M; Barbero U; Buccheri D; Cavallino C; Lombardi P; Bernelli C; D'Ascenzo F; Infantino V; Gambino A; Cinconze S; Rognoni A; Montagna L; Porto I; Musumeci G; Escaned J; Varbella F;
Eur Heart J; 2021 Aug; 42(33):3161-3171. PubMed ID: 34338759
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
